TY  - GEN
AU  - Mascarenhas,John
AU  - Sandy,Lonette
AU  - Lu,Min
AU  - Yoon,James
AU  - Petersen,Bruce
AU  - Zhang,David
AU  - Ye,Fei
AU  - Newsom,Carrie
AU  - Najfeld,Vesna
AU  - Hochman,Tsivia
AU  - Goldberg,Judith D
AU  - Hoffman,Ronald
TI  - A phase II study of panobinostat in patients with primary myelofibrosis (PMF) and post-polycythemia vera/essential thrombocythemia myelofibrosis (post-PV/ET MF)
SN  - 1873-5835
PY  - 2017///0728
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Female
KW  - Histone Deacetylase Inhibitors
KW  - Humans
KW  - Hydroxamic Acids
KW  - Indoles
KW  - Janus Kinase 2
KW  - genetics
KW  - Male
KW  - Middle Aged
KW  - Organ Size
KW  - Panobinostat
KW  - Polycythemia Vera
KW  - drug therapy
KW  - Primary Myelofibrosis
KW  - Spleen
KW  - pathology
KW  - Thrombocythemia, Essential
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase II; Journal Article
UR  - https://doi.org/10.1016/j.leukres.2016.11.015
ER  -